Sagimet Biosciences Inc. (SGMT)

NASDAQ: SGMT · Real-Time Price · USD

6.39

+0.04 (0.63%)

At close: Dec 5, 2025, 4:00 PM EST

6.27

-0.12 (-1.88%)

After-hours: Dec 5, 2025, 5:58 PM EST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Therapeutics for the Treatment of Metabolic Dysfunction-associated Steatohepatitis and Other Diseases	2.00M

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	2.00M